Chinese drug developer Jiangsu Atom Bioscience & Pharmaceutical has raised $30 million in Series B funding led by Sequoia Capital China and Hong Kong-listed Livzon Pharmaceutical Group.
Other investors include Kaitai Capital and Fortune Caizhi Venture Capital. The proceeds will be used to advance the global phase-two clinical trials of a treatment for gout. Phase-one trials have already...
Manila-based private equity firm Navegar has closed its second Philippines fund with $197 million in commitments. The initial target was $150 million.
Singapore-headquartered investment firm Blue Ashva Capital has secured a first close of INR4.5 billion ($60 million) for an India-domiciled fund that will invest in small and medium-sized enterprises (SMEs) and start-ups.
Investcorp has led a $56 million Series C round for Indian managed co-living accommodation platform operator Zolo.
Energy giant BP has agreed to invest $70 million in Green Growth Equity Fund (GGEF), a PE vehicle co-managed by Everstone Group that invests in sustainable infrastructure projects in India.